EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"Prophylaxis"
Narrow search

Narrow search

Year of publication
Subject
All
prophylaxis 8 Kinder 4 Children 3 Gesundheitsrisiko 3 Gesundheitsvorsorge 3 Infektionskrankheit 3 health sector 3 social services 3 Congenital heart disease 2 Cost-effectiveness 2 Epidemiology 2 Gross National Income 2 Großbritannien 2 HIV 2 HIV testing 2 HIV/AIDS 2 Health risk 2 Infectious disease 2 Ministry of Health 2 Nutrition 2 Palivizumab 2 Poverty Reduction Strategy Papers 2 Preventive care 2 Prophylaxis 2 Respiratory syncytial virus 2 STIs 2 Spain 2 TB 2 UNAIDS 2 United Kingdom 2 adolescents 2 air pollution 2 antenatal care 2 cases of AIDS 2 childbearing 2 condom 2 condom distribution 2 condom use 2 cost-effectiveness 2 drug therapy 2
more ... less ...
Online availability
All
Free 13
Type of publication
All
Article 7 Book / Working Paper 6
Type of publication (narrower categories)
All
Article 2 Article in journal 2 Aufsatz in Zeitschrift 2 Graue Literatur 1 Non-commercial literature 1
Language
All
Undetermined 8 English 5
Author
All
Basterra, Alejandra Rivas 2 Bentley, Anthony 2 Büsch, Katharina 2 Filipovic, Ivana 2 Gooch, Katherine 2 Grubb, ElizaBeth 2 López, Constancio Medrano 2 Majer, Istvan 2 Román, Natalia García 2 Schmidt, Ralph 2 Vargas, Veronica 2 Bloor, Karen 1 Chari, Abigail 1 Galván, María del Carmen Amaya 1 Lavadenz, Fernando 1 Maynard, Alan 1 Medici, Andre 1 Medvedeva Marina I. 1 Miachon, Lais 1 Peláez, Manuel J. 1 ИВАНОВНА, МЕДВЕДЕВА МАРИНА 1
more ... less ...
Institution
All
Economics Research, World Bank Group 2 International Monetary Fund 2 International Monetary Fund (IMF) 2 Centre for Health Economics, Department of Economics and Related Studies 1
Published in...
All
Health Economics Review 2 Health economics review 2 IMF Staff Country Reports 2 AERC research paper 1 Contribuciones a las Ciencias Sociales 1 Health, Nutrition and Population (HNP) Discussion Paper Series 1 Health, Nutrition and Population (HNP) Knowledge Briefs 1 The Problems of Economy 1 Working Papers / Centre for Health Economics, Department of Economics and Related Studies 1 Проблемы экономики 1
more ... less ...
Source
All
RePEc 8 ECONIS (ZBW) 3 EconStor 2
Showing 1 - 10 of 13
Did you mean: subject:"prophylaxe" (2,310 results)
Cover Image
Association between malaria prophylaxis stock-outs, and birth and maternal outcomes in Zimbabwe
Chari, Abigail - 2025
Persistent link: https://www.econbiz.de/10015195318
Saved in:
Cover Image
Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease: A novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain
Schmidt, Ralph; Majer, Istvan; Román, Natalia García; … - In: Health Economics Review 7 (2017) 47, pp. 1-8
children with congenital heart disease (CHD). This study estimated the cost-effectiveness of palivizumab prophylaxis versus … later years, was constructed to evaluate the benefits and costs associated with palivizumab versus no prophylaxis among … Spanish guidelines, costs and effects were discounted at 3%. Results: Over a lifetime horizon, palivizumab prophylaxis yielded …
Persistent link: https://www.econbiz.de/10012010755
Saved in:
Cover Image
Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease : a novel cost-utility modeling study reflecting evidence-based clinical pathways in Spain
Schmidt, Ralph; Majer, Istvan; Román, Natalia García; … - In: Health economics review 7 (2017) 47, pp. 1-8
children with congenital heart disease (CHD). This study estimated the cost-effectiveness of palivizumab prophylaxis versus … later years, was constructed to evaluate the benefits and costs associated with palivizumab versus no prophylaxis among … Spanish guidelines, costs and effects were discounted at 3%. Results: Over a lifetime horizon, palivizumab prophylaxis yielded …
Persistent link: https://www.econbiz.de/10011764192
Saved in:
Cover Image
The New HIV/AIDS Program in Peru: The Role of Prioritizing and Budgeting for Results
Vargas, Veronica - Economics Research, World Bank Group - 2015
XXX
Persistent link: https://www.econbiz.de/10011183009
Saved in:
Cover Image
HIV response using budgeting for results in HIV/AIDS programs : lessons from Peru
Medici, Andre; Vargas, Veronica; Lavadenz, Fernando; … - Economics Research, World Bank Group - 2014
Peru reduced its HIV/AIDS burden by 43 percent from 2000 to 2010 due to the introduction of free antiretroviral drug therapy in 2004, and the successful execution of the 2007-2011 HIV/AIDS Strategy and budgeting for results since 2011. The national HIV program received significant external...
Persistent link: https://www.econbiz.de/10011213764
Saved in:
Cover Image
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom /
Bentley, Anthony; Filipovic, Ivana; Gooch, Katherine; … - In: Health Economics Review 3 (2013) 18, pp. 1-12
risk. The study assesses the cost-effectiveness of palivizumab versus no prophylaxis in infants at high risk of … infants at high risk of severe RSV infection who receive either prophylaxis with palivizumab or no prophylaxis. The main …: Prophylaxis with palivizumab compared with no prophylaxis is associated with the following ICERs; £33,216 for infants with …
Persistent link: https://www.econbiz.de/10011599769
Saved in:
Cover Image
A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
Bentley, Anthony; Filipovic, Ivana; Gooch, Katherine; … - In: Health economics review 3 (2013) 18, pp. 1-12
risk. The study assesses the cost-effectiveness of palivizumab versus no prophylaxis in infants at high risk of … infants at high risk of severe RSV infection who receive either prophylaxis with palivizumab or no prophylaxis. The main …: Prophylaxis with palivizumab compared with no prophylaxis is associated with the following ICERs; £33,216 for infants with …
Persistent link: https://www.econbiz.de/10009783228
Saved in:
Cover Image
ГИБКАЯ ПРОИЗВОДСТВЕННАЯ СИСТЕМА С ПЕРЕНАЛАДКОЙ, НЕНАДЕЖНЫМ ОБОРУДОВАНИЕМ, ВОССТАНОВЛЕНИЕМ И ПРОФИЛАКТИКОЙ
ИВАНОВНА, МЕДВЕДЕВА МАРИНА - In: Проблемы экономики (2012) 3, pp. 54-58
В статье рассмотрен вопрос определения стационарных вероятностей состояний системы массового обслуживания с ненадежным прибором, переналадкой и...
Persistent link: https://www.econbiz.de/10011226437
Saved in:
Cover Image
Flexible Manufacturing System with Changeover, Unreliable Device, Vacation and Prophylaxis
Medvedeva Marina I. - In: The Problems of Economy (2012) 2, pp. 54-58
, vacation and prophylaxis describing functioning of both basic and auxiliary material stream of the logistic system is …
Persistent link: https://www.econbiz.de/10010639194
Saved in:
Cover Image
Kyrgyz Republic; Medium-Term Development Program: Poverty Reduction Strategy Paper
International Monetary Fund (IMF); International … - 2012
This paper focuses on the Medium-Term Development Program for the Kyrgyz Republic. The aim of this program is to put the economy of the country into a sustainable vector of development and improve the budget status to prevent social effects, increase living standard, and reduce poverty in the...
Persistent link: https://www.econbiz.de/10011244609
Saved in:
  • 1
  • 2
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...